» Articles » PMID: 20922055

Functional Mechanisms for Human Tumor Suppressors

Overview
Journal J Cancer
Specialty Oncology
Date 2010 Oct 6
PMID 20922055
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor suppressors refer to a large group of molecules that are capable of controlling cell division, promoting apoptosis, and suppressing metastasis. The loss of function for a tumor suppressor may lead to cancer due to uncontrolled cell division. Because of their importance, extensive studies have been undertaken to understand the different functional mechanisms of tumor suppressors. Here, we briefly review the four major mechanisms, inhibition of cell division, induction of apoptosis, DNA damage repair, and inhibition of metastasis. It is noteworthy that some tumor suppressors, such as p53, may adopt more than one mechanism for their functions.

Citing Articles

Prognostic and functional role of the nuclear export receptor 1 (XPO1) in gastrointestinal cancers: a potential novel target?.

Sokolova V, Gruber R, Pammer L, Kocher F, Klieser E, Amann A Mol Biol Rep. 2024; 52(1):87.

PMID: 39729162 PMC: 11680630. DOI: 10.1007/s11033-024-10169-5.


Tumors Established in a Defective Immune Environment Reprogram the Oncogenic Signaling Pathways to Escalate Tumor Antigenicity.

Ke C, Wu H, Wang Y, Huang W, Lin C Biomedicines. 2024; 12(4).

PMID: 38672200 PMC: 11047836. DOI: 10.3390/biomedicines12040846.


Advancements in elucidating the pathogenesis of actinic keratosis: present state and future prospects.

Wang Z, Wang X, Shi Y, Wu S, Ding Y, Yao G Front Med (Lausanne). 2024; 11:1330491.

PMID: 38566927 PMC: 10985158. DOI: 10.3389/fmed.2024.1330491.


Haploinsufficiency of Adenomatous Polyposis Coli Coupled with Kirsten Rat Sarcoma Viral Oncogene Homologue Activation and P53 Loss Provokes High-Grade Glioblastoma Formation in Mice.

Fang K, Su C, Layos J, Lau N, Cheng K Cancers (Basel). 2024; 16(5).

PMID: 38473403 PMC: 10930734. DOI: 10.3390/cancers16051046.


Contribution of Autophagy to Epithelial Mesenchymal Transition Induction during Cancer Progression.

Strippoli R, Niayesh-Mehr R, Adelipour M, Khosravi A, Cordani M, Zarrabi A Cancers (Basel). 2024; 16(4).

PMID: 38398197 PMC: 10886827. DOI: 10.3390/cancers16040807.


References
1.
Weller M, Kleihues P, Dichgans J, Ohgaki H . CD95 ligand: lethal weapon against malignant glioma?. Brain Pathol. 1998; 8(2):285-93. PMC: 8098168. DOI: 10.1111/j.1750-3639.1998.tb00154.x. View

2.
Meehan W, Samant R, Hopper J, Carrozza M, Shevde L, Workman J . Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma-binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem. 2003; 279(2):1562-9. DOI: 10.1074/jbc.M307969200. View

3.
Nakanishi K, Taniguchi T, Ranganathan V, New H, Moreau L, Stotsky M . Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol. 2002; 4(12):913-20. DOI: 10.1038/ncb879. View

4.
Hannon G, Beach D . p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994; 371(6494):257-61. DOI: 10.1038/371257a0. View

5.
Vaziri C, Saxena S, Jeon Y, Lee C, Murata K, Machida Y . A p53-dependent checkpoint pathway prevents rereplication. Mol Cell. 2003; 11(4):997-1008. DOI: 10.1016/s1097-2765(03)00099-6. View